Medications for Cryptococcal Meningitis, Immunosuppressed Host

Cryptococcal meningitis is a fungal infection of the tissues covering the brain and spinal cord (meninges), caused by the fungus Cryptococcus neoformans. Cryptococcal meningitis most often affects people with a weakened immune system.

Drugs used to treat Cryptococcal Meningitis, Immunosuppressed Host

The following list of medications are in some way related to or used in the treatment of this condition.

Drug name	Rating	Reviews	Rx/OTC	Pregnancy	CSA
fluconazole	9.0	1 review	Rx	C	N
Generic name: fluconazole systemic Brand name: Diflucan Drug class: azole antifungals For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information

amphotericin b	Rate	Add review	Rx	B	N
Generic name: amphotericin b systemic Brand names: Amphocin, Fungizone Drug class: polyenes For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information

Diflucan	9.0	1 review	Rx	C	N
Generic name: fluconazole systemic Drug class: azole antifungals For consumers: dosage, interactions, side effects For professionals: Prescribing Information

flucytosine	Rate	Add review	Rx	C	N
Generic name: flucytosine systemic Brand name: Ancobon Drug class: miscellaneous antifungals For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information

AmBisome	Rate	Add review	Rx	B	N
Generic name: amphotericin b liposomal systemic Drug class: polyenes For consumers: dosage, interactions, side effects

Sporanox	Rate	Add review	Rx	C	N
Generic name: itraconazole systemic Drug class: azole antifungals For consumers: dosage, interactions, side effects For professionals: Prescribing Information

Amphocin	Rate	Add review	Rx	B	N
Generic name: amphotericin b systemic Drug class: polyenes For consumers: dosage, interactions, side effects

amphotericin b liposomal	Rate	Add review	Rx	B	N
Generic name: amphotericin b liposomal systemic Brand name: AmBisome Drug class: polyenes For consumers: dosage, interactions, side effects

Ancobon	Rate	Add review	Rx	C	N
Generic name: flucytosine systemic Drug class: miscellaneous antifungals For consumers: dosage, interactions, side effects For professionals: Prescribing Information

Fungizone	Rate	Add review	Rx	B	N
Generic name: amphotericin b systemic Drug class: polyenes For consumers: dosage, interactions, side effects For professionals: Prescribing Information

itraconazole	Rate	Add review	Rx	C	N
Generic name: itraconazole systemic Brand name: Sporanox Drug class: azole antifungals For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information

Legend

Rating	For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity	Activity is based on recent site visitor activity relative to other medications in the list.
Rx	Prescription only.
OTC	Over-the-counter.
Rx/OTC	Prescription or Over-the-counter.
Off-label	This medication may not be approved by the FDA for the treatment of this condition.
EUA	An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.

Pregnancy Category
A	Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B	Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C	Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D	There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X	Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N	FDA has not classified the drug.

Controlled Substances Act (CSA) Schedule
M	The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U	CSA Schedule is unknown.
N	Is not subject to the Controlled Substances Act.
1	Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2	Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3	Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4	Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5	Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.

Alcohol
X	Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer